Notices

• Bulk Drug Substances That May Be Used To Compound Drug Products in Accordance With Section 503B of the Federal Food, Drug, and Cosmetic Act, Concerning Outsourcing Facilities; Revised Request for Nominations

  

• Bulk Drug Substances That May Be Used To Compound Drug Products in Accordance With Section 503A of the Federal Food, Drug, and Cosmetic Act; Revised Request for Nominations

  

• Global Unique Device Identification Database; Guidance for Industry and Food and Drug Administration Staff; Availability

  

• Scientific Information Request on Interventions To Improve Appropriate Antibiotic Use for Acute Respiratory Tract Infections

  

• Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Recordkeeping and Records Access Requirements for Food Facilities

  

• Agency Information Collection Activities; Proposed Collection; Comment Request; Requirements for Submission of Bioequivalence Data

  

• Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Additional Criteria and Procedures for Classifying Over-the-Counter Drugs as Generally Recognized as Safe and Effective and Not Misbranded

  

• Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Index of Legally Marketed Unapproved New Animal Drugs for Minor Species

  

• Privacy Act of 1974 Report of New System of Records

  

• Scientific Information Request on Diagnosis and Treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)

  

• American Indians Into Psychology

  

• Prospective Grant of Exclusive License for: Silica-Coated Fluorescent Nanodiamond Probes and Devices and Systems for Imaging Fluorescent Nanodiamonds

  

• Global Unique Device Identification Database; Guidance for Industry; Availability

  

• Draft Guidance for Industry on Providing Submissions in Electronic Format-Postmarketing Safety Reports; Availability

  

• Announcement of the Re-Approval of AABB (Foremerly Known as the American Association of Blood Banks) as an Accreditation Organization Under the Clinical Laboratory Improvement Amendments of 1988

  

• Documents To Support Submission of an Electronic Common Technical Document; Availability

  

• Medicare Program; The Advisory Panel on Hospital Outpatient Payment (HOP Panel) Summer Meeting, August 25-26, 2014

  

• Agency Information Collection Activities; Proposed Collection; Comment Request; Prescription Drug Labeling Improvement and Enhancement Initiative

  

• Patient Safety Organizations: Voluntary Relinquishment From Medical Peer Review Resource, LLC

  

• Statement of Organization, Functions and Delegations of Authority